Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Insulin Signaling: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Insulin Signaling is a biological pathway involved in neurodegeneration research. Key relationships include: activates, therapeutic target, interacts with. Associated with ALS, Aging, Als. Connected to 291 entities in the SciDEX knowledge graph.
| Name | Insulin Signaling |
| Summary | # [Brain Insulin Signaling](/entities/brain-insulin-signaling) ## Introduction [Brain Insulin Signaling](/entities/brain-insulin-signaling) is an important component in the neurobiology of neurodegen |
| Key Genes/Proteins | PI3K, INSULIN RESISTANCE, INFLAMMATION, GLP-1 |
| Related Diseases | Als, Inflammation, Aging, Insulin Resistance, Alzheimer's Disease |
Knowledge base pages for this entity
graph TD
Insulin_Signaling["Insulin Signaling"] -->|"interacts"| Cholesterol["Cholesterol"]
Insulin_Signaling["Insulin Signaling"] -->|"interacts"| Glycolysis["Glycolysis"]
Insulin_Signaling["Insulin Signaling"] -->|"interacts"| Mtor["Mtor"]
Insulin_Signaling["Insulin Signaling"] -->|"interacts"| Synaptic_Plasticity["Synaptic Plasticity"]
Insulin_Signaling["Insulin Signaling"] -->|"interacts"| Nf__b["Nf-Kappab"]
JUN["JUN"] -->|"activates"| Insulin_Signaling["Insulin Signaling"]
MTOR["MTOR"] -->|"activates"| Insulin_Signaling["Insulin Signaling"]
AKT["AKT"] -->|"activates"| Insulin_Signaling["Insulin Signaling"]
GENES["GENES"] -->|"activates"| Insulin_Signaling["Insulin Signaling"]
style Insulin_Signaling fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Insulin Resistance | involved_in | phenotype | 0.90 |
| Alzheimer's Disease | involved_in | disease | 0.90 |
| Parkinson's Disease | involved_in | disease | 0.90 |
| Cognitive Function | regulates | phenotype | 0.90 |
| Mitochondrial Dysfunction | regulates | process | 0.90 |
| Glucose Disposal | regulates | phenotype | 0.90 |
| NEURODEGENERATION | protects_against | process | 0.88 |
| TAU | regulates | protein | 0.85 |
| Insulin Resistance | causes | phenotype | 0.80 |
| Tau Hyperphosphorylation | inhibits | process | 0.80 |
| Autophagy | regulates | process | 0.80 |
| Retinal Ganglion Cell Neuroprotection | involved_in | mechanism | 0.80 |
| Retinal Ganglion Cell | modulates | cell_type | 0.75 |
| Cholesterol | interacts_with | pathway | 0.55 |
| Glycolysis | interacts_with | pathway | 0.55 |
| Mtor | interacts_with | pathway | 0.55 |
| Synaptic Plasticity | interacts_with | pathway | 0.55 |
| Nf-Κb | interacts_with | pathway | 0.55 |
| INSULIN | activates | concept | 0.50 |
| RAPAMYCIN | activates | concept | 0.50 |
| INSULIN | associated_with | concept | 0.50 |
| Proteins | associated_with | protein | 0.50 |
| AXON | protects_against | concept | 0.50 |
| INSULIN | protects_against | concept | 0.50 |
| Neuroprotection | protects_against | process | 0.50 |
| Pi3K/Akt | activates | pathway | 0.50 |
| disease | activates | disease | 0.50 |
| PI3K/AKT/mTOR | activates | pathway | 0.50 |
| Pi3K/Akt | inhibits | pathway | 0.50 |
| INSULIN | inhibits | concept | 0.50 |
| PI3K/AKT/mTOR | inhibits | pathway | 0.50 |
| disease | regulates | disease | 0.50 |
| ALZHEIMER'S | regulates | concept | 0.50 |
| INSULIN | regulates | concept | 0.50 |
| disease | associated_with | disease | 0.50 |
| ALZHEIMER'S | associated_with | concept | 0.50 |
| GLUCOSE METABOLISM | activates | concept | 0.50 |
| IRS1 | activates | concept | 0.50 |
| disease | inhibits | disease | 0.50 |
| NEURONS | inhibits | concept | 0.50 |
| ALZHEIMER'S | inhibits | concept | 0.50 |
| ALZHEIMER'S | activates | concept | 0.50 |
| CHRONIC INFLAMMATION | inhibits | concept | 0.50 |
| ENDOTHELIAL | activates | concept | 0.50 |
| ENDOTHELIAL CELLS | activates | concept | 0.50 |
| ENDOTHELIAL | associated_with | concept | 0.50 |
| Nephropathy | associated_with | disease | 0.50 |
| ENDOTHELIAL CELLS | associated_with | concept | 0.50 |
| IRS1 | associated_with | concept | 0.50 |
| GLUTAMATE | associated_with | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| PI3K | activates | gene | 1.00 |
| INSULIN RESISTANCE | activates | gene | 1.00 |
| Aging | activates | disease | 1.00 |
| Insulin Resistance | activates | disease | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| GLP-1 | associated_with | protein | 0.95 |
| GLP-1 | promotes | protein | 0.95 |
| AKT | component_of | protein | 0.90 |
| MTOR | component_of | protein | 0.90 |
| GLP-1R | activates | receptor | 0.90 |
| MTOR | activates | gene | 0.90 |
| AKT | activates | gene | 0.90 |
| GENES | activates | gene | 0.90 |
| Alzheimer | activates | disease | 0.90 |
| Aging | therapeutic_target | disease | 0.90 |
| AGING | activates | gene | 0.90 |
| Glp-1 Receptor Agonists | associated_with | drug | 0.87 |
| Obesity | activates | disease | 0.80 |
| Diabetes | activates | disease | 0.80 |
| Diabetes | contributes_to | disease | 0.80 |
| Neurodegeneration | contributes_to | disease | 0.80 |
| Cardiovascular | activates | disease | 0.80 |
| Diabetes | therapeutic_target | disease | 0.80 |
| INSULIN RESISTANCE | therapeutic_target | gene | 0.80 |
| OXIDATIVE STRESS | contributes_to | gene | 0.80 |
| AKT | regulates | gene | 0.80 |
| NEURODEGENERATION | contributes_to | gene | 0.80 |
| INSULIN RESISTANCE | contributes_to | gene | 0.80 |
| Insulin Resistance | contributes_to | disease | 0.80 |
| TAU | activates | gene | 0.80 |
| APOPTOSIS | activates | gene | 0.80 |
| ALZHEIMER | activates | gene | 0.80 |
| ALZHEIMER'S DISEASE | activates | gene | 0.80 |
| ALZHEIMER | associated_with | gene | 0.80 |
| AMYLOID | activates | gene | 0.80 |
| Alzheimer | associated_with | disease | 0.80 |
| Neurodegeneration | activates | disease | 0.75 |
| Alzheimer | contributes_to | disease | 0.70 |
| Inflammation | contributes_to | disease | 0.70 |
| PI3K | therapeutic_target | gene | 0.70 |
| AKT | therapeutic_target | gene | 0.70 |
| PI3K | associated_with | gene | 0.70 |
| AKT | associated_with | gene | 0.70 |
| Inflammation | therapeutic_target | disease | 0.70 |
| Alzheimer | therapeutic_target | disease | 0.70 |
| MTORC1 | activates | gene | 0.70 |
| MTOR | inhibits | gene | 0.70 |
| AMPK | activates | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||